BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paran H, Mayo A, Paran D, Neufeld D, Shwartz I, Zissin R, Singer P, Kaplan O, Skornik Y, Freund U. Octreotide treatment in patients with severe acute pancreatitis. Dig Dis Sci. 2000;45:2247-2251. [PMID: 11215748 DOI: 10.1023/a:1026679106463] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Ladd AM, Conwell D, Burroughs TE, Satish M. Prior Exposure to Nonsteroidal Anti-inflammatory Drugs Reduces the Rate of Organ Failure and In-Hospital Mortality in Acute Pancreatitis. Am J Med 2022;135:471-477.e1. [PMID: 34793751 DOI: 10.1016/j.amjmed.2021.10.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Mas E, Borrelli O, Broekaert I, de-Carpi JM, Dolinsek J, Miele E, Pienar C, Koninckx CR, Thomassen RA, Thomson M, Tzivinikos C, Benninga MA. Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders. J Pediatr Gastroenterol Nutr 2022;74:1-6. [PMID: 34508049 DOI: 10.1097/MPG.0000000000003294] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wang H, Jiang Y, Li H, Wang J, Li C, Zhang D. Carbachol protects the intestinal barrier in severe acute pancreatitis by regulating Cdc42/F-actin cytoskeleton. Exp Ther Med 2020;20:2828-37. [PMID: 32765779 DOI: 10.3892/etm.2020.8985] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Siregar GA, Siregar GP. Management of Severe Acute Pancreatitis. Open Access Maced J Med Sci 2019;7:3319-23. [PMID: 31949538 DOI: 10.3889/oamjms.2019.720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
5 Sliwinska-Mosson M, Marek G, Grzebieniak Z, Milnerowicz H. Relationship between somatostatin and interleukin-6: A cross-sectional study in patients with acute pancreatitis. Pancreatology 2018;18:885-91. [PMID: 30279074 DOI: 10.1016/j.pan.2018.09.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Afghani E, Pandol SJ, Shimosegawa T, Sutton R, Wu BU, Vege SS, Gorelick F, Hirota M, Windsor J, Lo SK, Freeman ML, Lerch MM, Tsuji Y, Melmed GY, Wassef W, Mayerle J. Acute Pancreatitis-Progress and Challenges: A Report on an International Symposium. Pancreas 2015;44:1195-210. [PMID: 26465949 DOI: 10.1097/MPA.0000000000000500] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
7 Kambhampati S, Park W, Habtezion A. Pharmacologic therapy for acute pancreatitis. World J Gastroenterol 2014; 20(45): 16868-16880 [PMID: 25493000 DOI: 10.3748/wjg.v20.i45.16868] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
8 Li J, Yang WJ, Huang LM, Tang CW. Immunomodulatory therapies for acute pancreatitis. World J Gastroenterol 2014; 20(45): 16935-16947 [PMID: 25493006 DOI: 10.3748/wjg.v20.i45.16935] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
9 Feng YC, Wang M, Zhu F, Qin RY. Study on acute recent stage pancreatitis. World J Gastroenterol 2014; 20(43): 16138-16145 [PMID: 25473166 DOI: 10.3748/wjg.v20.i43.16138] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
10 Zhou MT, Chen BC, Sun HW, Jin YP, Yang FJ, Zhang X, Andersson R, Zhang QY. Continuous regional arterial infusion with fluorouracil and octreotide attenuates severe acute pancreatitis in a canine model. PLoS One. 2012;7:e37347. [PMID: 22655040 DOI: 10.1371/journal.pone.0037347] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
11 Deng ZG, Zhou JY, Yin ZY, Peng YY, Wang FQ, Wang XM. Continuous regional arterial infusion and laparotomic decompression for severe acute pancreatitis with abdominal compartment syndrome. World J Gastroenterol 2011; 17(44): 4911-4916 [PMID: 22171133 DOI: 10.3748/wjg.v17.i44.4911] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
12 Xiping Z, Jie Z, Qin X, Guanghua F, Yang C, Tongfa J, Qi X. Influence of baicalin and octreotide on NF-kappaB and p-selectin expression in liver and kidney of rats with severe acute pancreatitis. Inflammation. 2009;32:1-11. [PMID: 19030975 DOI: 10.1007/s10753-008-9096-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
13 Zhang XP, Zhang J, Ren Z, Feng GH, Zhu W, Cai Y, Yang QJ, Ju TF, Xie Q, Yuan WQ. Study on protecting effects of Baicalin and Octreotide on hepatic injury in rats with severe acute pancreatitis. World J Gastroenterol 2008; 14(42): 6551-6559 [PMID: 19030211 DOI: 10.3748/wjg.14.6551] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhang XP, Tian H, Lai YH, Chen L, Zhang L, Cheng QH, Yan W, Li Y, Li QY, He Q, Wang F. Protective effects and mechanisms of Baicalin and octreotide on renal injury of rats with severe acute pancreatitis. World J Gastroenterol 2007; 13(38): 5079-5089 [PMID: 17876873 DOI: 10.3748/wjg.v13.i38.5079] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
15 Zhang XP, Zhang L, He JX, Zhang RP, Cheng QH, Zhou YF, Lu B. Experimental study of therapeutic efficacy of Baicalin in rats with severe acute pancreatitis. World J Gastroenterol 2007; 13(5): 717-724 [PMID: 17278194 DOI: 10.3748/wjg.v13.i5.717] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
16 Banks PA, Freeman ML; Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101:2379-400. [PMID: 17032204 DOI: 10.1111/j.1572-0241.2006.00856.x] [Cited by in Crossref: 1150] [Cited by in F6Publishing: 971] [Article Influence: 71.9] [Reference Citation Analysis]
17 Heinrich S, Schäfer M, Rousson V, Clavien PA. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg. 2006;243:154-168. [PMID: 16432347 DOI: 10.1097/01.sla.0000197334.58374.70] [Cited by in Crossref: 230] [Cited by in F6Publishing: 192] [Article Influence: 14.4] [Reference Citation Analysis]
18 Xia Q, Yuan L, Yang XN, Tang WF, Jiang JM. Comparison of integrated Chinese and Western medicine with and without somatostatin supplement in the treatment of severe acute pancreatitis. World J Gastroenterol 2005; 11(7): 1073-1076 [PMID: 15742419 DOI: 10.3748/wjg.v11.i7.1073] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
19 Chen YD, Zhou ZG, Wang Z, Gao HK, Yan WW, Wang C, Zhao GP, Peng XH. Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats. World J Gastroenterol 2005; 11(4): 538-544 [PMID: 15641142 DOI: 10.3748/wjg.v11.i4.538] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
20 Adhikari N, Burns KE, Meade MO. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2004;:CD004477. [PMID: 15495113 DOI: 10.1002/14651858.CD004477.pub2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
21 Mössner J, Keim V. [Therapy of chronic pancreatitis]. Internist (Berl) 2003;44:1515-23. [PMID: 14689194 DOI: 10.1007/s00108-003-1068-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]